Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Finasteride reduces hair growth better, but spironolactone has more side effects.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

Diane 35 plus finasteride is more effective for treating hirsutism.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Adequate testosterone is crucial for men's health and quality of life, but its decline with age needs more research.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Flutamide reduces hair growth better but has more side effects.

Finasteride effectively treats hirsutism in women, but more research needed for long-term results.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

There's no significant link between the D19S884 marker at the insulin receptor gene and polycystic ovary syndrome.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Birth control pills and cyproterone acetate can help treat acne in women, especially when linked to hormonal issues.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.